AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Merck Confirms Favorable Cardiovascular Safety Profile of Vioxx(R).

PR Newswire

| May 22, 2001 | COPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

UPPER GWYNEDD, Pa., May 22 /PRNewswire/ --

In response to news and analyst reports of data the Company first released a year ago, Merck & Co., Inc. today reconfirmed the favorable cardiovascular safety profile of Vioxx(R) (rofecoxib), its medicine that selectively inhibits COX-2. Vioxx was approved by the Food and Drug Administration in May 1999 for the management of osteoarthritis and the relief of acute pain in adults based on efficacy and safety studies involving nearly 4,000 patients. More than 33 million prescriptions have been written for Vioxx in the United States since its introduction.

The results of the Vioxx Gastrointestinal Research study were first released in March 2000. Since that time, the data have been widely reported, published in The New England Journal of Medicine and…

Related articles from newspapers, magazines, journals, and more
FDA Arthritis Advisory Committee Reviews Merck's Application for Revised...
Press release article from: PR Newswire February 8, 2001 700+ words
...results from the Vioxx Gastrointestinal...study. The Advisory Committee agreed with Merck...the labeling for Vioxx. The FDA is not...advice of the Advisory Committee, but usually...discussions, the Advisory Committee explored this...other studies of Vioxx and ...
My days at the FDA advisory committee meetings on Vioxx.(RX News)
Newspaper article from: HealthFacts Levin, Arthur A. April 1, 2005 700+ words
...unprecedented three-day FDA advisory committee meeting of outside...blockbuster arthritis drugs, Vioxx, Celebrex and Bextra...scientific evidence that Vioxx, Celebrex or Bextra...that a third of the advisory committee members had troubling...votes on Bextra and Vioxx. Prior to ...
FDA Advisory Committee Meeting on Vioxx(TM) Confirmed for April 20.
Press release article from: PR Newswire February 25, 1999 700+ words
...s (FDA) Arthritis Advisory Committee meeting has been scheduled for April 20, 1999, for Vioxx(TM) (rofecoxib...New Drug Application for Vioxx on Nov. 23, 1998. On...Medco Managed Care. Vioxx(TM) is the Merck trademark...
FDA Advisory Committee Acknowledges the GI Safety Data for Both COX-2...
Press release article from: PR Newswire February 8, 2001 700+ words
...Pharmacia and Pfizer Inc today announced that the Arthritis Advisory Committee to the U.S. Food and Drug Administration (FDA) has...deliberation, provided guidance to FDA that the labels for both Vioxx (rofecoxib) and CELEBREX (R) (celecoxib capsules) should...
Vioxx could return to market if benefits outweigh risks.
News wire article from: Knight Ridder/Tribune Business News February 18, 2005 700+ words
...painkillers that includes Vioxx. "If the advisory committee and the FDA conclude...the unique benefits Vioxx offers," he said...may have died from Vioxx's side effects...Cox-2s." The advisory committee, composed of medical...
Vioxx could return to market if benefits outweigh risks.(Knight Ridder...
News wire article from: Knight Ridder/Tribune News Service Mondics, Chris February 18, 2005 700+ words
...painkillers that includes Vioxx. "If the advisory committee and the FDA conclude...the unique benefits Vioxx offers," he said...may have died from Vioxx's side effects...CAN END HERE) The advisory committee, composed of medical...
FDA's COX-2 Recommendations Will Benefit Bextra and Celebrex Though Physicians...
Press release article from: PR Newswire March 23, 2005 700+ words
...PRNewswire/ -- New FDA Advisory Committee Recommendations around...to shy away from Vioxx, even if it returns...inquired about the Vioxx return. Questions...risks surrounding Vioxx. New FDA Advisory Committee Recommendations Spur...
Event Brief of Media Briefing To Discuss the Previously Announced Market...
News wire article from: Fair Disclosure Wire October 13, 2004 700+ words
...cardiovascular event rates between VIOXX and placebo. 3. MRK concluded...prescribing information for VIOXX. 10. In February 2001, FDA held a public advisory committee meeting to review data...designed to determine if VIOXX could help prevent recurrence...
Merck official: All drugs like Vioxx may cause heart problems, strokes.
News wire article from: The America's Intelligence Wire February 17, 2005 700+ words
...indications of heart problems with Vioxx before it was withdrawn, but...Administration's arthritis advisory committee and its drug safety and risk management advisory committee, which are looking into Vioxx, Celebrex and Bextra. Celebrex...
Merck leaves open possibility of reintroducing Vioxx.
News wire article from: The America's Intelligence Wire February 18, 2005 700+ words
...consider returning pain medication Vioxx to the market if a Food and Drug Administration advisory committee decides risks associated with the...data given the unique benefits Vioxx offers." The FDA's panel will...
For more facts and information, see all results

Source: HighBeam Research, Merck Confirms Favorable Cardiovascular Safety Profile of Vioxx(R).

©2010 Gale, a part of Cengage Learning. All rights reserved. About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily